Literature DB >> 15627816

Choline acetyltransferase, glutamic acid decarboxylase and somatostatin in the kainic acid model for chronic temporal lobe epilepsy.

Halina Baran1, Berthold Kepplinger, Markus Draxler, Gerhard Skofitsch.   

Abstract

The aim of the study was to investigate neurochemical changes in a kainic acid (KA; 10 mg/kg, s.c.)-induced spontaneous recurrent seizure model of epilepsy, 6 months after the initial KA-induced seizures. The neuronal markers of cholinergic and gamma-aminobutyric acid (GABA)ergic systems, i.e. choline acetyltransferase (ChAT) and glutamic acid decarboxylase (GAD) activities, and a marker for neuropeptide, i.e. level of somatostatin, have been investigated. The brain regions investigated were the hippocampus, amygdala/piriform cortex, caudate nucleus, substantia nigra and the frontal, parietal, temporal and occipital cortices. Six months after KA injection, reduced ChAT activity was observed in the amygdala/piriform cortex (47% of control; p<0.001), increased ChAT activity in the hippocampus (119% of control; p<0.01) and normal ChAT activity in the other brain regions. The activity of GAD was significantly increased in all analysed cortical regions (between 146 and 171% of control), in the caudate nucleus (144% of control; p<0.01) and in the substantia nigra (126% of control; p<0.01), whereas in the amygdala/piriform cortex, the GAD activity was moderately lowered. The somatostatin level was significantly increased in all cortical regions (between 162 and 221% of control) as well as in the hippocampus (119% of control), but reduced in the amygdala/piriform cortex (45% of control; p<0.01). Six months after KA injection, the somatostatin:GAD ratio was lowered in the amygdala/piriform cortex (49% of control) and in the caudate nucleus (41% of control), whereas it was normal in the hippocampus and moderately increased in the cortical brain regions. A positive correlation was found between seizure severity and the reduction of both ChAT activities and somatostatin levels in the amygdala/piriform cortex. The results show a specific pattern of changes for cholinergic, GABAergic and somatostatinergic activities in the chronic KA model for epilepsy. The revealed data suggest a functional role for them in the new network that follows spontaneous repetitive seizures. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627816     DOI: 10.1159/000081964

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  6 in total

Review 1.  Effects of Prolonged Seizures on Basal Forebrain Cholinergic Neurons: Evidence and Potential Clinical Relevance.

Authors:  Filippo Sean Giorgi; Alessandro Galgani; Anderson Gaglione; Rosangela Ferese; Francesco Fornai
Journal:  Neurotox Res       Date:  2020-04-21       Impact factor: 3.911

2.  Reduced astrocytic contribution to the turnover of glutamate, glutamine, and GABA characterizes the latent phase in the kainate model of temporal lobe epilepsy.

Authors:  Silje Alvestad; Janniche Hammer; Hong Qu; Asta Håberg; Ole Petter Ottersen; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-27       Impact factor: 6.200

3.  Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy.

Authors:  Silje Alvestad; Janniche Hammer; Elvar Eyjolfsson; Hong Qu; Ole Petter Ottersen; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

4.  Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis.

Authors:  B Fritsch; F Qashu; T H Figueiredo; V Aroniadou-Anderjaska; M A Rogawski; M F M Braga
Journal:  Neuroscience       Date:  2009-06-18       Impact factor: 3.590

5.  Compensatory Mechanisms Modulate the Neuronal Excitability in a Kainic Acid-Induced Epilepsy Mouse Model.

Authors:  Gaojie Pan; Zhicai Chen; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng; Yanfang Li
Journal:  Front Neural Circuits       Date:  2018-06-29       Impact factor: 3.492

Review 6.  The functions of repressor element 1-silencing transcription factor in models of epileptogenesis and post-ischemia.

Authors:  Ruth Butler-Ryan; Ian C Wood
Journal:  Metab Brain Dis       Date:  2021-04-04       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.